Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.3301
+0.0071 (2.20%)
At close: Feb 17, 2026, 4:00 PM EST
0.3090
-0.0211 (-6.39%)
After-hours: Feb 17, 2026, 7:59 PM EST
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $8.94 million as of February 17, 2026. Its market cap has decreased by -52.51% in one year.
Market Cap
8.94M
Enterprise Value
6.44M
1-Year Change
-52.51%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $8.94M, a decrease of -95.47%. That is a compound annual growth rate of -46.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.75M | -7.13% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | 197.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 9.58M |
| Bolt Biotherapeutics | 9.50M |
| CalciMedica | 9.44M |
| Chemomab Therapeutics | 9.29M |
| Pulmatrix | 8.89M |
| NuCana | 8.82M |
| SeaStar Medical Holding | 8.65M |
| XTL Biopharmaceuticals | 8.57M |